mirtazapine has been researched along with Dysthymic Disorder in 9 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Dysthymic Disorder: Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. (DSM-IV)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is an antidepressant which has been recently released on the U." | 6.69 | Dysthymic disorder: treatment with mirtazapine. ( Bea, C; Budech, CB; Dunner, DL; Hendrickson, HE; O'Connor, E, 1999) |
| "Mirtazapine is an antidepressant which has been recently released on the U." | 2.69 | Dysthymic disorder: treatment with mirtazapine. ( Bea, C; Budech, CB; Dunner, DL; Hendrickson, HE; O'Connor, E, 1999) |
| "Mirtazapine is an antidepressant with mode of action different from other currently available antidepressants." | 2.40 | Mirtazapine: other indications. ( Falkai, P, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HM | 1 |
| Yang, YH | 1 |
| Chen, KJ | 1 |
| Lee, Y | 1 |
| McIntyre, RS | 1 |
| Lu, ML | 1 |
| Lee, YC | 1 |
| Hsieh, MC | 1 |
| Chen, VC | 1 |
| Ladeira, RB | 1 |
| Cunha, FT | 1 |
| Salgado, JV | 1 |
| Teixeira, AL | 1 |
| Nicolato, R | 1 |
| Dholakia, R | 1 |
| Schleifer, SJ | 1 |
| Ahmad, YJ | 1 |
| Narang, IS | 1 |
| Rubio, G | 1 |
| San, L | 1 |
| López-Muñoz, F | 1 |
| Alamo, C | 1 |
| Elstner, S | 1 |
| Burian, R | 1 |
| Diefenbacher, A | 1 |
| Soutullo, CA | 1 |
| McElroy, SL | 1 |
| Keck, PE | 1 |
| Falkai, P | 1 |
| Dunner, DL | 1 |
| Hendrickson, HE | 1 |
| Bea, C | 1 |
| Budech, CB | 1 |
| O'Connor, E | 1 |
| Klesmer, J | 1 |
| Sarcevic, A | 1 |
| Fomari, V | 1 |
2 reviews available for mirtazapine and Dysthymic Disorder
| Article | Year |
|---|---|
[Depression in family practice].
Topics: Age Factors; Aged; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Depressive Disord | 2007 |
Mirtazapine: other indications.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Dis | 1999 |
2 trials available for mirtazapine and Dysthymic Disorder
| Article | Year |
|---|---|
Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug R | 2004 |
Dysthymic disorder: treatment with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Huma | 1999 |
5 other studies available for mirtazapine and Dysthymic Disorder
| Article | Year |
|---|---|
Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cohort Studies; Co | 2019 |
[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; De | 2008 |
Delayed-onset mirtazapine-related leukopenia and rechallenge.
Topics: Adult; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Dysthymic Disorder; Femal | 2010 |
Hypomania associated with mirtazapine augmentation of sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug | 1998 |
Panic attacks during discontinuation of mirtazepine.
Topics: Antidepressive Agents, Tricyclic; Appendectomy; Dysthymic Disorder; Hernia, Umbilical; Humans; Male; | 2000 |